Skip to main content

Advertisement

Log in

Refining the origins of breast cancer

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Cyclin D1 may be overexpressed in most breast cancers. Is this a critical early step in breast carcinogenesis (pages 1257–1260)?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Rosai, J. Borderline epithelial lesions of the breast. Am. J. Surg. Path. 15, 209–221 (1991).

    Article  CAS  PubMed  Google Scholar 

  2. Rosen, P.P. Proliferative breast “ disease,” an unresolved diagnostic dilemma. Cancer 71, 3798–3807 (1993).

    Article  CAS  PubMed  Google Scholar 

  3. Bose, S., Lesser, M.L., Norton, L. & Rosen, P.P. Immunophenotype of intraductal carcinoma. Arch. Pathol. Lab. Med. 120, (in the press).

  4. Chen, Y. et al. Aberrant subcellular localization of BRCA1 in breast cancer. Science 270, 789–791 (1995).

    Article  CAS  PubMed  Google Scholar 

  5. Weinstat-Saslow, D. et al. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med. 1, 1257–1260 (1995).

    Article  CAS  PubMed  Google Scholar 

  6. Motokura, T. & Arnold, A. PRAD1/cyclin Dl proto-oncogene: Genomic organization, 5′DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chrom. Cancer 7, 89–95 (1993).

    Article  CAS  PubMed  Google Scholar 

  7. Buckley, M.F. et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8, 2127–2133 (1993).

    CAS  PubMed  Google Scholar 

  8. Sherr, C.J. Cycling on Cue. Cell 79, 551–555 (1994).

    Article  CAS  PubMed  Google Scholar 

  9. Lukas, J., Aagaard, L., Strauss, M. & Bartek, J. Oncogenic aberrations of p16INK4/CDKN2 and cyclin Dl cooperate to deregulate G1, control. Cancer Res. 55, 4818–4823 (1995).

    CAS  PubMed  Google Scholar 

  10. Wang, T.C. et al. Mammary hyperplasia and carcinoma in MMTV-cyclin Dl transgenic mice. Nature 369, 669–671 (1994).

    Article  CAS  PubMed  Google Scholar 

  11. Sicinski, P. et al. Cyclin Dl provides a link between development and oncogenesis in the retina and breast. Cell 82, 621–630 (1995).

    Article  CAS  PubMed  Google Scholar 

  12. Rosenwald, I.E., Lzaris-Karatzas, A., Sonenberg, N. & Schmidt, E.V. Elevated levels of cyclin Dl protein in response to increased expression of eukaryotic initiation factor 4E. Molec. cell. Biol. 13, 7358–7363 (1993).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Musgrove, E.A. et al. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Molec. cell. Biol. 13, 3577–3587 (1993).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Gilewski, T. & Norton, L. Cytokinetics of breast cancer.inDiseases of the Breast (eds Harris, J.R., Lippmanm, M.E., Morrow, M. & Hellman, S.) (J.B. Lippincott, New York, in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Norton, L., Rosen, P. & Rosen, N. Refining the origins of breast cancer. Nat Med 1, 1250–1251 (1995). https://doi.org/10.1038/nm1295-1250

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1295-1250

  • Springer Nature America, Inc.

This article is cited by

Navigation